Menu Back to 16th-DIA-Japan-Annual-Meeting-2019

Overview

Join us as at the DIA Japan Annual Meeting 2019, to discuss these topics and the future of healthcare.

Download Program



At DIA, we are here to continue challenging by exerting leadership with a collaboration among industry, government and academia to create a new value in pharmaceutical and medical device development. Needless to say, how to work effectively together is as important as the individual leadership. By maintaining ethics, transparency and fairness, avoiding the conflict of interest and enabling the synergism, a better rational collaboration can be achieved. As a result, our goal is to provide rational medicine with breakthrough innovation to all the current and future people. The 16th DIA Japan Annual Meeting, with a theme of “In Order to Deliver Rational Medicine to all the people in the world,” is a place for discussion, thinking and opinion exchange to contribute to medical environment in the future.

We look forward to welcoming you at Tokyo Big Sight from November 10-12, 2019 for stimulating discussions around promoting better collaboration to drive global health and innovation in this era of medical and scientific transformation.

Program Committee

  • Tatsuya Kondo, MD, PhD
    Tatsuya Kondo, MD, PhD • President
    SH Medical Excellence JAPAN, Japan
  • Takashi Sato, MSc, PMP
    Takashi Sato, MSc, PMP •
    PM Orchestra Takashi Sato, Japan
  • Hiroya Asou, MD, PhD, MBA
    Hiroya Asou, MD, PhD, MBA • Senior Medical Advisor, Global Patient Safety Japan
    Eli Lilly Japan K.K., Japan
  • Noriko Fujiwara, MS, RN
    Noriko Fujiwara, MS, RN • Project Researcher, Oncology nurse
    IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Japan
  • Yoshikata Furuya, MSc
    Yoshikata Furuya, MSc • Manager, General Affairs Division
    Sankeien Hoshoukai Foundation, Japan
  • Toshinori Higashi, PhD
    Toshinori Higashi, PhD • Vice President, Regulatory Science
    KAKEN PHARMACEUTICAL CO.,LTD., Japan
  • Kazuo Ichikawa, PhD, PMP
    Kazuo Ichikawa, PhD, PMP • yyy
    Xxx, Japan
  • Katsuhiko Ichimaru
    Katsuhiko Ichimaru • Review Director, Office of New Drug IV
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Toshiko Ishibashi, PhD, RN
    Toshiko Ishibashi, PhD, RN • Associate Director,Oncology Medical Science Department
    Daiichi Sankyo Company, Limited, Japan
  • Yoichi M. Ito, PhD
    Yoichi M. Ito, PhD • Director
    Hokkaido University Hospital, Institute of Health Science Innovation, Japan
  • Miyuki Kaneko
    Miyuki Kaneko • Japan Regulatory Portfolio Lead, Regulatory Affairs
    Pfizer R&D Japan G.K., Japan
  • Yoko Kazami, RPh, PMP
    Yoko Kazami, RPh, PMP • Manager, Research & Development
    Nobelpharma Co., Ltd., Japan
  • Noriatsu Kono, MPharm
    Noriatsu Kono, MPharm • Organizational management
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Arisa Maeda
    Arisa Maeda • CMC Regulatory Affairs, Regulatory Affairs Area, Japan Development
    MSD K.K., Japan
  • Noriaki Nagao, MPharm, PMP
    Noriaki Nagao, MPharm, PMP • Clinical Development Dept. Pharmaceutical Division
    JAPAN TOBACCO INC., Japan
  • Motohide Nishi, MBA
    Motohide Nishi, MBA • Japan Site Leader & VP Professional Services
    Medidata Solutions K.K., Japan
  • Minori Niso
    Minori Niso • Brand Marketing Director, APAC Marketing
    Parexel, Japan
  • Hiromi Okabe, PhD
    Hiromi Okabe, PhD • Immunology, Regulatory Affairs Japan,Global Drug Development Division
    Novartis Pharma K.K, Japan
  • Hiroshi Sakaguchi
    Hiroshi Sakaguchi • Reviewer, Office of New Drug II
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Norio Shimazaki
    Norio Shimazaki • Director, Regional Clinical Operations Japan, Korea and Taiwan
    Bristol-Myers Squibb K.K., Japan
  • Mikiko Shitara
    Mikiko Shitara • Senior Manager, Regulatory Affairs Dept.
    Alexionpharma GK, Japan
  • Kuniko Shoji
    Kuniko Shoji • Vice-Dean, School of Health Innovation
    Kanagawa University of Human Services, Japan
  • Keiko Tsumori, MSc
    Keiko Tsumori, MSc • Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
    MSD K.K., Japan
  • Tadashi Urashima, PhD
    Tadashi Urashima, PhD • Performance and Digital Analytics Lead, Medical & Development Excellence Japan
    GlaxoSmithKline K.K., Japan
  • Manami Yoshida, DVM
    Manami Yoshida, DVM • Associate Director, Medical Affairs – HIV & COVID-19
    Gilead Sciences K.K., Japan
  • Koichiro Yuji, MD, PhD, FACP
    Koichiro Yuji, MD, PhD, FACP • Project Associate Professor, The Institute of Medical Science
    Japan
  • Kazuhiro Kanmuri, PhD
    Kazuhiro Kanmuri, PhD • Vice President, Product Development and Clinical Operations
    Ascent Development Services Inc, Japan
  • Kazumichi Kobayashi, RPh
    Kazumichi Kobayashi, RPh • Executive Deputy President (Board Member)
    Otsuka Medical Devices Co., Ltd., Japan
  • Junichi Nishino, MSc, RPh
    Junichi Nishino, MSc, RPh • Head, Regulatory Affairs Department
    Otsuka Pharmaceutical Co., Ltd., Japan
  • Hironobu Saito, PhD
    Hironobu Saito, PhD • Corporate Advisor
    Daiichi Sankyo Co., Ltd., Japan
  • Junko Sato, PhD
    Junko Sato, PhD • Associate Executive Director
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Eri Sekine
    Eri Sekine • Executive Vice President
    CMIC Co., Ltd., Japan
  • Atsushi Tsukamoto, PhD, MSc
    Atsushi Tsukamoto, PhD, MSc • Corporate Officer, Head is Therapeutic Area Strategies
    Daiichi Sankyo, United States
Load More